- Home
- KMB vs COR Comparison
KMB vs COR Comparison
Compare KMB & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMB
- COR
- Stock Information
- Founded
- KMB 1910
- COR 2001
- Country
- KMB United States
- COR United States
- Employees
- KMB N/A
- COR N/A
- Industry
- KMB Containers/Packaging
- COR Other Pharmaceuticals
- Sector
- KMB Consumer Discretionary
- COR Health Care
- Exchange
- KMB Nasdaq
- COR Nasdaq
- Market Cap
- KMB 43.4B
- COR 49.1B
- IPO Year
- KMB N/A
- COR N/A
- Fundamental
- Price
- KMB $133.08
- COR $282.99
- Analyst Decision
- KMB Hold
- COR Buy
- Analyst Count
- KMB 12
- COR 10
- Target Price
- KMB $145.08
- COR $299.60
- AVG Volume (30 Days)
- KMB 2.4M
- COR 1.7M
- Earning Date
- KMB 04-22-2025
- COR 05-07-2025
- Dividend Yield
- KMB 3.79%
- COR 0.78%
- EPS Growth
- KMB 34.72
- COR N/A
- EPS
- KMB 7.34
- COR 8.59
- Revenue
- KMB $19,749,000,000.00
- COR $310,232,192,000.00
- Revenue This Year
- KMB N/A
- COR $11.10
- Revenue Next Year
- KMB $2.32
- COR $6.87
- P/E Ratio
- KMB $18.12
- COR $32.96
- Revenue Growth
- KMB N/A
- COR 12.19
- 52 Week Low
- KMB $124.10
- COR $214.77
- 52 Week High
- KMB $150.45
- COR $309.35
- Technical
- Relative Strength Index (RSI)
- KMB 44.97
- COR 48.90
- Support Level
- KMB $129.76
- COR $290.05
- Resistance Level
- KMB $134.88
- COR $309.35
- Average True Range (ATR)
- KMB 2.73
- COR 7.00
- MACD
- KMB 0.13
- COR -1.06
- Stochastic Oscillator
- KMB 47.78
- COR 22.90
About KMB Kimberly-Clark Corporation
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
About COR Cencora Inc.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.